| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173555A1 Method and kit for indicating the level of bad breath |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173548A2 Materials and methods relating to neuronal development |
| 01/23/2002 | EP1173520A1 Novel amidopyrylium fluorescence dyes |
| 01/23/2002 | EP1173519A1 Novel carbopyronine fluorescence dyes |
| 01/23/2002 | EP1173486A1 Antibodies that recognize app cleaved by caspases and methods of use |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173283A1 Centrifuging device and use of same |
| 01/23/2002 | EP1173202A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1056856B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/23/2002 | EP1049744B1 Asymmetric cyanine dye quenchers |
| 01/23/2002 | EP0968303A4 Method and system for performing a binding assay |
| 01/23/2002 | EP0968275A4 Method and apparatus for treating materials with electrical fields having varying orientations |
| 01/23/2002 | EP0944736A4 Methods and compositions for the diagnosis of extraesophageal gastric reflux |
| 01/23/2002 | EP0934523A4 Method and apparatus useful for detecting bloodgroup antigens and antibodies |
| 01/23/2002 | EP0920631B1 Method for identifying compounds affecting rna/rna binding protein interactions |
| 01/23/2002 | EP0888545B1 Super-paramagnetic particles with increased r 1 relaxivity, processes for producing said particles and use thereof |
| 01/23/2002 | EP0846124B1 Chemical, biochemical and biological processing in thin films |
| 01/23/2002 | EP0840802B1 Method of sequencing by oligomer hybridisation |
| 01/23/2002 | EP0821790B1 On-line coupling of biochemical detection to continuous-flow separation techniques |
| 01/23/2002 | EP0704056B9 Leukocyte adhesion assay |
| 01/23/2002 | EP0685069A4 Dry chemistry cascade immunoassay and affinity assay |
| 01/23/2002 | EP0658118B1 Vaccines against group c neisseria meningitidis |
| 01/23/2002 | EP0470164B1 Analytical apparatus |
| 01/23/2002 | CN2473618Y Micro integrated biochemical analysis chip |
| 01/23/2002 | CN2473613Y Fecal collecting holder |
| 01/23/2002 | CN1332849A Methods and compositions to lower plasma cholesterol levels |
| 01/23/2002 | CN1332848A Methods for providing liquid solid components of sample for use in assay methods |
| 01/23/2002 | CN1332847A Substance containing shiitake mushroom hypha extract for soreening lak activity and method for screening lak activity by using the same |
| 01/23/2002 | CN1332842A Method of testing cell sample |
| 01/23/2002 | CN1332805A Multiplex amplification of short tandem repeat loci |
| 01/23/2002 | CN1332804A Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 01/23/2002 | CN1332796A Method for separating viral particles |
| 01/23/2002 | CN1332750A Modified treponema pallidum outer membrane protein, its immunoassay use and immunoassay kit |
| 01/23/2002 | CN1332749A HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332685A Systems and methods for modifying ice adhesion strength |
| 01/23/2002 | CN1332625A Nanocapsules and method of production thereof |
| 01/23/2002 | CN1332603A Concurrent in ovo injection and detection method and apparatus |
| 01/23/2002 | CN1332375A Method for differentiation and enrichment of cell specific target structure |
| 01/23/2002 | CN1332367A Method and device for measuring concentration of suspension |
| 01/23/2002 | CN1332366A Fluid rheological characteristics measuring method adopting annular flowing device |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/22/2002 | US6341256 Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination |
| 01/22/2002 | US6341173 Device and method for the determination of diameters of crystals |
| 01/22/2002 | US6340892 Hand-held digital moisture meter with memory and communications |
| 01/22/2002 | US6340744 Spectrofluorimetrically detection macrocyclic complex |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340675 Process for the production of an anticoagulant composition |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340599 Terbium, dysprosium, samarium, osmium, or ruthenium complex with unsaturated oxyaryl compound |
| 01/22/2002 | US6340598 Apparatus for multichannel fluorescent immunoassays |
| 01/22/2002 | US6340589 Thin-well microplate and methods of making same |
| 01/22/2002 | US6340578 High speed determination of three-dimensional structure using isotopes; polypeptide biosynthesis |
| 01/22/2002 | US6340571 Antibodies specific for Staphylococcus aureus, and use thereof |
| 01/22/2002 | US6340570 Detection and characterization of microorganisms |
| 01/22/2002 | US6340568 Method for detecting and classifying nucleic acid hybridization |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | US6340431 SPA chemistry monitor and treatment unit |
| 01/22/2002 | US6340418 Slag oxygen sensor |
| 01/22/2002 | US6340412 Method for determining the detaching angle and/or the detaching profile of a paper web |
| 01/22/2002 | US6339966 Bulk powder sampler with removable partitions and method of using |
| 01/22/2002 | US6339954 Method of analyzing concentration of target substance using quartz oscillator and device therefor |
| 01/22/2002 | CA2161704C Electrochemiluminescence assay |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/22/2002 | CA2129368C Assay verification control for analytical methods |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA2025330C Characterizing biological matter in a dynamic condition using near infrared spectroscopy |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/20/2002 | CA2353200A1 Ionization polarity prediction of compounds for efficient mass spectrometry |
| 01/19/2002 | CA2327013A1 Web assembly machine |
| 01/18/2002 | CA2349743A1 Diagnostic assay |
| 01/18/2002 | CA2314237A1 Method and apparatus for estimating odor concentration using an electronic nose |
| 01/17/2002 | WO2002005146A2 Method for disigning protein libraries with altered immunogenicity |
| 01/17/2002 | WO2002005059A2 Medical system, method and apparatus employing mems |
| 01/17/2002 | WO2002004972A1 Method and system to determine physical properties by nmr relaxation-time measurements |
| 01/17/2002 | WO2002004959A1 Measurements of inositol phospholipid mass |
| 01/17/2002 | WO2002004958A1 Method for determining potential alterations of a substance having biological activities |
| 01/17/2002 | WO2002004957A2 Fourier transform mass spectrometry of complex biological samples |
| 01/17/2002 | WO2002004956A2 Method of identifying conformation-sensitive binding peptides and uses thereof |
| 01/17/2002 | WO2002004955A2 Assay method and system for identification of p2y receptor agonists and antagonists |
| 01/17/2002 | WO2002004954A2 Early diagnosis of conformational diseases |
| 01/17/2002 | WO2002004953A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 01/17/2002 | WO2002004951A1 Micro-array |
| 01/17/2002 | WO2002004950A2 Direct assessment of analyte to reference molecule ratios |
| 01/17/2002 | WO2002004949A2 Reagents and methods for identification of binding agents |
| 01/17/2002 | WO2002004948A2 Distinguishing molecular forms |
| 01/17/2002 | WO2002004947A2 Spectrophotometric system and method for the identification and characterization of a particle in a bodily fluid |